The prevalence of germline DICER1 pathogenic variation in cancer populations
- PMID: 30672147
- PMCID: PMC6418698
- DOI: 10.1002/mgg3.555
The prevalence of germline DICER1 pathogenic variation in cancer populations
Abstract
Background: The DICER1 syndrome is an autosomal dominant tumor-predisposition disorder associated with pleuropulmonary blastoma, a rare pediatric lung cancer. Somatic missense variation in "hotspot" codons in the RNaseIIIb domain (E1705, D1709, G1809, D1810, E1813) is observed in DICER1-associated tumors. Previously, we found the prevalence of germline pathogenic DICER1 variation in the general population is 1:10,600. In this study, we investigated the prevalence of pathogenic DICER1 germline variation in The Cancer Genome Atlas (TCGA; 32 adult cancer types; 9,173 exomes) and the Therapeutically Applicable Research to Generate Effective Treatment (TARGET; two pediatric cancer types; 175 exomes) cohorts.
Methods: All datasets were annotated and binned into four categories: pathogenic, likely pathogenic, variant of unknown significance, or likely benign.
Results: The prevalence of DICER1 pathogenic variants was 1:4,600 in TCGA. A single participant with a uterine corpus endometrial carcinoma harbored two pathogenic germline DICER1 (hotspot and splice-donor) variants, and a single participant with a rectal adenocarcinoma harbored a germline DICER1 stop-gained variant. In the smaller TARGET dataset, we observed no pathogenic germline variants.
Conclusion: This is the largest comprehensive analysis of DICER1 pathogenic variation in adult and pediatric cancer populations using publicly available data. The observation of germline DICER1 variation with uterine corpus endometrial carcinoma merits additional investigation.
Keywords: DICER1; DICER1 syndrome; TARGET; TCGA; cancer population; prevalence estimate.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare no relevant conflicts of interest.
References
-
- Anglesio, M. S. , Wang, Y. , Yang, W. , Senz, J. , Wan, A. , Heravi‐Moussavi, A. , … Morin, G. B. (2013). Cancer‐associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse‐strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. The Journal of Pathology, 229(3), 400–409. 10.1002/path.4135 - DOI - PubMed
-
- Brenneman, M. A. , Field, A. , Yang, J. , Williams, G. , Doros, L. , Rossi, C. T. , … Hill, D. A. (2015). Temporal order of RNase IIIb and loss‐of‐function mutations during development determines phenotype in DICER1 syndrome: A unique variant of the two‐hit tumor suppression model. F1000 Research, 4, 214 10.12688/f1000research.6746.1 - DOI - PMC - PubMed
-
- Cho, S. H. , Ko, J. J. , Kim, J. O. , Jeon, Y. J. , Yoo, J. K. , Oh, J. , … Kim, N. K. (2015). 3'‐UTR polymorphisms in the MiRNA machinery genes DROSHA, DICER1, RAN, and XPO5 are associated with colorectal cancer risk in a Korean population. PLoS ONE, 10(7), e0131125 10.1371/journal.pone.0131125 - DOI - PMC - PubMed
-
- Cingolani, P. , Platts, A. , le Wang, L. , Coon, M. , Nguyen, T. , Wang, L. , … Ruden, D. M. (2012). A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso‐2; iso‐3. Fly (Austin), 6(2), 80–92. 10.4161/fly.19695 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
